Impact of CYP2C19 Genotype-guided Clopidogrel and Ticagrelor Treatment on Platelet Function Test and Metabolomics Profile

NCT05516784 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease (CAD)

Interventions

DRUG: Clopidogrel
DRUG: Ticagrelor

Sponsor

Universiti Sains Malaysia